Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.
All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.
CiteScore:
CiteScore
SJR
SNIP
CiteScore排名
6.5
0.792
0.753
学科
排名
百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Toxicology
Pub Date : 2024-10-30DOI: 10.1016/j.reprotox.2024.108741Luc Mohimont, Chris Anagnostopoulos, Maria Anastassiadou, Anna Federica Castoldi, Adeline Cavelier, Tamara Coja, Peter Craig, Federica Crivellente, Bruno Dujardin, Andy Hart, Wim Hooghe, Samira Jarrah, Kyriaki Machera, Elena Menegola, Francesca Metruccio, Christian Sieke